Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Neurodegeneration and Neuroprotection in Glaucoma.

Gauthier AC, Liu J.

Yale J Biol Med. 2016 Mar 24;89(1):73-9. eCollection 2016 Mar.

2.

Neuroprotection in Glaucoma.

Doozandeh A, Yazdani S.

J Ophthalmic Vis Res. 2016 Apr-Jun;11(2):209-20. doi: 10.4103/2008-322X.183923. Review.

3.

Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice.

van der Heijden ME, Shah P, Cowan CS, Yang Z, Wu SM, Frankfort BJ.

Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3077-87. doi: 10.1167/iovs.16-19312.

PMID:
27286365
4.

Neuroprotective Effects of Low-Dose Statins in the Retinal Ultrastructure of Hypercholesterolemic Rabbits.

Fernández-Navarro J, Aldea P, de Hoz R, Salazar JJ, Ramírez AI, Rojas B, Gallego BI, Triviño A, Tejerina T, Ramírez JM.

PLoS One. 2016 May 4;11(5):e0154800. doi: 10.1371/journal.pone.0154800. eCollection 2016.

5.

Roles of CYP2C19 Gene Polymorphisms in Susceptibility to POAG and Individual Differences in Drug Treatment Response.

Liu XL, Jia QJ, Wang LN, Liu ZM, Liu H, Duan XC, Lyu XM.

Med Sci Monit. 2016 Jan 29;22:310-5.

6.

Vascular and autonomic dysregulation in primary open-angle glaucoma.

Pasquale LR.

Curr Opin Ophthalmol. 2016 Mar;27(2):94-101. doi: 10.1097/ICU.0000000000000245. Review.

PMID:
26720776
7.

Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension.

Sharma S, Trikha S, Perera SA, Aung T.

Clin Ophthalmol. 2015 Nov 24;9:2201-7. doi: 10.2147/OPTH.S72380. eCollection 2015. Review.

8.

Current perspective of neuroprotection and glaucoma.

Tian K, Shibata-Germanos S, Pahlitzsch M, Cordeiro MF.

Clin Ophthalmol. 2015 Nov 11;9:2109-18. doi: 10.2147/OPTH.S80445. eCollection 2015. Review.

9.

Two-Year Clinical Results After Selective Laser Trabeculoplasty for Normal Tension Glaucoma.

Lee JW, Shum JJ, Chan JC, Lai JS.

Medicine (Baltimore). 2015 Jun;94(24):e984. doi: 10.1097/MD.0000000000000984.

10.

Present and New Treatment Strategies in the Management of Glaucoma.

M K.

Open Ophthalmol J. 2015 May 15;9:89-100. doi: 10.2174/1874364101509010089. eCollection 2015.

11.

Neuroprotective therapies for glaucoma.

Song W, Huang P, Zhang C.

Drug Des Devel Ther. 2015 Mar 11;9:1469-79. doi: 10.2147/DDDT.S80594. eCollection 2015. Review.

12.

Pharmacotherapy of glaucoma.

Schmidl D, Schmetterer L, Garhöfer G, Popa-Cherecheanu A.

J Ocul Pharmacol Ther. 2015 Mar;31(2):63-77. doi: 10.1089/jop.2014.0067. Epub 2015 Jan 14. Review.

13.

Novel therapies for open-angle glaucoma.

Wentz SM, Kim NJ, Wang J, Amireskandari A, Siesky B, Harris A.

F1000Prime Rep. 2014 Nov 4;6:102. doi: 10.12703/P6-102. eCollection 2014. Review.

14.

Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results.

Lee JW, Ho WL, Chan JC, Lai JS.

BMC Ophthalmol. 2015 Jan 8;15:1. doi: 10.1186/1471-2415-15-1.

15.

Effect on intraocular pressure of switching from latanoprost and travoprost monotherapy to timolol fixed combinations in patients with normal-tension glaucoma.

Igarashi R, Togano T, Sakaue Y, Yoshino T, Ueda J, Fukuchi T.

J Ophthalmol. 2014;2014:720385. doi: 10.1155/2014/720385. Epub 2014 Nov 19.

16.

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma.

Seibold LK, Kahook MY.

Clin Ophthalmol. 2014 Oct 31;8:2189-93. doi: 10.2147/OPTH.S73125. eCollection 2014.

17.

Biomarkers and surrogate endpoints in glaucoma clinical trials.

Medeiros FA.

Br J Ophthalmol. 2015 May;99(5):599-603. doi: 10.1136/bjophthalmol-2014-305550. Epub 2014 Jul 17. Review.

18.

Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.

Semba K, Namekata K, Kimura A, Harada C, Mitamura Y, Harada T.

Cell Death Dis. 2014 Jul 17;5:e1341. doi: 10.1038/cddis.2014.306.

19.

Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy.

Wang Y, Wang Y, Yang Q, Guo L, Yin Y, Fan N, Zhou X, Cai SP, Kaufman PL, Liu X.

Exp Eye Res. 2014 Aug;125:128-34. doi: 10.1016/j.exer.2014.05.018. Epub 2014 Jun 11.

20.

Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.

Buys ES, Potter LR, Pasquale LR, Ksander BR.

Front Mol Neurosci. 2014 May 19;7:38. doi: 10.3389/fnmol.2014.00038. eCollection 2014. Review.

Items per page

Supplemental Content

Write to the Help Desk